Oxana Beskrovnaya, Chief Scientific Officer at Dyne Therapeutics, Inc. (DYN), sold 4,746 shares at $25.85 ($123K) on 2024-03-07, disclosed to the SEC on 2024-03-11.
Scheduled sale ($123k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.85 | 2,373 | $61K | 50.0% |
| 2 | $25.85 | 2,373 | $61K | 50.0% |
| Total | $25.85 avg | 4,746 | $123K | 100% |
| Filing → |
| DYN | SELL | 2025-02-25 | $36K | — | Filing → |
| DYN | SELL | 2024-12-11 | $131K | — | Filing → |
| DYN | SELL | 2024-11-18 | $161K | — | Filing → |